Clinical Trial Update: Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating different starting doses of atorvastatin to achieve cholesterol targets.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Arteriosclerosis
• Dyslipidemia
• Peripheral Vascular Disease
• Stroke
• Type 2 Diabetes Mellitus

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Coronary Arteriosclerosis, Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED